Conducting Robust Oversight
We’re conducting robust oversight to examine how to rebuild and restore critical functions of key agencies that were dismantled during the four years of the Trump Administration. We continue to work to ensure that Washington is working for the people not the special interests.
- Investigated the Texas power crisis and the importance of making the nation’s electric grid more resilient: Following a letter to Texas Governor Gregg Abbott demanding answers on the power outage crisis and a letter to Electric Reliability Council of Texas (ERCOT) inquiring about its role in the extreme weather event, the Oversight and Investigations Subcommittee held a hearing on March 24, 2021, examining the failures that occurred as well as what lessons must be learned to prevent history from repeating itself.
- Examined social media’s role in promoting extremism and misinformation: Held a joint Communications and Technology Subcommittee and Consumer Protection and Commerce Subcommittee hearing with the CEOs of Facebook, Twitter, and Google. Committee Democrats continued to hold online platforms accountable for the growing rise of misinformation and disinformation. This hearing followed previous oversight letters to Facebook and YouTube.
- Examined how to restore the mission of the Environmental Protection Agency (EPA) after it was seriously undermined during the Trump Administration: The Oversight and Investigations Subcommittee held a hearing on how to rebuild the EPA and undo the damage done to the agency over the last four years.
- Held four oversight hearings on availability, distribution, and supply of COVID-19 vaccines, as well as vaccine hesitancy: The first three hearings examined how states, vaccine manufacturers, and the Biden Administration are working to increase COVID-19 vaccines and to ensure they are equitably distributed. The vaccine hesitancy hearing examined how to continue building trust in the safety and efficacy of vaccines, reduce access barriers and encourage unvaccinated Americans to get their shots.
- Demanded answers on cyberattacks: Bipartisan Committee leaders sent a letter to federal agencies within the Committee’s jurisdiction seeking additional information on the impacts of the SolarWinds cyberattack. Following the Colonial Pipeline cyberattack, Committee leaders organized a bipartisan briefing with Department of Energy (DOE) officials to better understand the impact its closure had across the country.
- Bipartisan leaders wrote to the Department of Health and Human Services (HHS) on Hospital Price Transparency: The Committee sent a bipartisan letter to HHS Secretary Xavier Becerra regarding implementation of the Hospital Price Transparency Final Rule, which went into effect on January 1, 2021, and the need to ensure that hospitals are complying with the new rule. The letter urged HHS to enforce the final rule to ensure hospitals are fully compliant with the disclosure requirements so that patients can readily access the price information for all items and services in an easy-to-use format.
- Committee investigates new Alzheimer’s drug pricing and approval: The Committee, along with the Committee on Oversight and Reform, began an investigation into the approval and pricing of Biogen Inc.’s Alzheimer’s drug, Aduhelm on June 25, 2021. The Committees will be looking to better understand why this drug was approved, how Biogen set its price and what impact this will have on research for future Alzheimer’s treatments and federal health care programs.
- Examining the well-being of unaccompanied children: The Biden Administration inherited unprecedented immigration challenges and is now tasked with humanely caring for and processing unaccompanied children seeking refuge. The Oversight and Investigations Subcommittee held a hearing on June 9, 2021, to hear the current challenges and to ensure the Administration receives the resources and support it needs to properly care for these children.